Chenguang Biotech Stock Soars 7.75%, Hits Intraday High of CNY 15.80

Chenguang Biotech Group Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.75% on March 12, 2026. The stock reached an intraday high of CNY 15.80, showcasing its strong market activity. Over the past week, Chenguang Biotech has surged by 14.76%, and its one-month performance stands at 13.84%, both outperforming the China Shanghai Composite index, which reported a slight decline. In terms of annual performance, Chenguang Biotech has delivered an impressive return of 70.76%, significantly higher than the 22.46% return of the broader market. Year-to-date, the stock has risen by 26.59%, further emphasizing its robust performance relative to the market. Despite these positive trends, the company has faced challenges, including a high debt-to-equity ratio and a decline in profits over the past year. However, it has reported a notable operating cash flow of CNY 590.45 million and a substantial cash position of CNY 6,235.1 million. With a dividend yield of 1.27% and a price-to-book ratio of 1.63, Chenguang Biotech continues to navigate a competitive FMCG landscape while demonstrating resilience in its financial metrics.